Refine
Year of publication
Language
- English (63)
Has Fulltext
- yes (63)
Is part of the Bibliography
- no (63)
Keywords
- Diffraction (2)
- Elastic scattering (2)
- RHIC (2)
- Attention (1)
- B-slope (1)
- Bipolar disorder (1)
- Canopy height model (1)
- Ceramides (1)
- Charged-particle multiplicity (1)
- Charm quark spatial diffusion coefficient (1)
- Charmonia (1)
- Coalescence (1)
- Cognition (1)
- Cognitive dysfunction (1)
- Cold nuclear matter effects (1)
- Collectivity (1)
- Correlation (1)
- Critical point (1)
- Deuteron production (1)
- Di-hadron correlations (1)
- Elliptic flow (1)
- Europe (1)
- Flow (1)
- GTP cyclohydrolase (1)
- Genetics (1)
- Groomed jet radius (1)
- Heavy Ion Experiments (1)
- Heavy Quark Production (1)
- Heavy-Ion Collision (1)
- Heavy-flavor decay electron (1)
- Heavy-ion (1)
- Heavy-ion collisions (1)
- Higher moments (1)
- Hippocampal excitability (1)
- IntelliCage (1)
- Interference fragmentation function (1)
- J/ψ suppression (1)
- Jet substructure (1)
- Long-term potentiation (1)
- Lysophosphatidic acids (1)
- Molecular biology (1)
- Multiple parton interactions (1)
- Nitric oxide (1)
- Nonflow (1)
- Omega lipids (1)
- Polarization (1)
- Proton-proton collisions (1)
- Proton–proton collisions (1)
- Quarkonium (1)
- STAR (1)
- Schizophrenia (1)
- Shear viscosity (1)
- SoftDrop (1)
- Spin alignment (1)
- Splitting function (1)
- T-cells (1)
- Tetrahydrobiopterin (1)
- Thermal model (1)
- Touchscreen (1)
- Transversity (1)
- UAV (1)
- Working memory capacity (1)
- drone (1)
- ectosomes (1)
- exosomes (1)
- extracellular vesicles (1)
- fine spatial resolution remote sensing (1)
- guidelines (1)
- microparticles (1)
- microvesicles (1)
- minimal information requirements (1)
- p+p collisions (1)
- perinatal HIV infection (1)
- plant height (1)
- reproducibility (1)
- rigor (1)
- standardization (1)
- structure-from-motion photogrammetry (1)
- virological failure (1)
- young people (1)
Institute
Recent studies suggest that synaptic lysophosphatidic acids (LPAs) augment glutamate-dependent cortical excitability and sensory information processing in mice and humans via presynaptic LPAR2 activation. Here, we studied the consequences of LPAR2 deletion or antagonism on various aspects of cognition using a set of behavioral and electrophysiological analyses. Hippocampal neuronal network activity was decreased in middle-aged LPAR2−/− mice, whereas hippocampal long-term potentiation (LTP) was increased suggesting cognitive advantages of LPAR2−/− mice. In line with the lower excitability, RNAseq studies revealed reduced transcription of neuronal activity markers in the dentate gyrus of the hippocampus in naïve LPAR2−/− mice, including ARC, FOS, FOSB, NR4A, NPAS4 and EGR2. LPAR2−/− mice behaved similarly to wild-type controls in maze tests of spatial or social learning and memory but showed faster and accurate responses in a 5-choice serial reaction touchscreen task requiring high attention and fast spatial discrimination. In IntelliCage learning experiments, LPAR2−/− were less active during daytime but normally active at night, and showed higher accuracy and attention to LED cues during active times. Overall, they maintained equal or superior licking success with fewer trials. Pharmacological block of the LPAR2 receptor recapitulated the LPAR2−/− phenotype, which was characterized by economic corner usage, stronger daytime resting behavior and higher proportions of correct trials. We conclude that LPAR2 stabilizes neuronal network excitability upon aging and allows for more efficient use of resting periods, better memory consolidation and better performance in tasks requiring high selective attention. Therapeutic LPAR2 antagonism may alleviate aging-associated cognitive dysfunctions.
Background: Alzheimer's disease is a common debilitating dementia with known heritability, for which 20 late onset susceptibility loci have been identified, but more remain to be discovered. This study sought to identify new susceptibility genes, using an alternative gene-wide analytical approach which tests for patterns of association within genes, in the powerful genome-wide association dataset of the International Genomics of Alzheimer's Project Consortium, comprising over 7 m genotypes from 25,580 Alzheimer's cases and 48,466 controls.
Principal findings: In addition to earlier reported genes, we detected genome-wide significant loci on chromosomes 8 (TP53INP1, p = 1.4×10−6) and 14 (IGHV1-67 p = 7.9×10−8) which indexed novel susceptibility loci.
Significance: The additional genes identified in this study, have an array of functions previously implicated in Alzheimer's disease, including aspects of energy metabolism, protein degradation and the immune system and add further weight to these pathways as potential therapeutic targets in Alzheimer's disease.
DNA methylation profiles of aggressive behavior may capture lifetime cumulative effects of genetic, stochastic, and environmental influences associated with aggression. Here, we report the first large meta-analysis of epigenome-wide association studies (EWAS) of aggressive behavior (N = 15,324 participants). In peripheral blood samples of 14,434 participants from 18 cohorts with mean ages ranging from 7 to 68 years, 13 methylation sites were significantly associated with aggression (alpha = 1.2 × 10−7; Bonferroni correction). In cord blood samples of 2425 children from five cohorts with aggression assessed at mean ages ranging from 4 to 7 years, 83% of these sites showed the same direction of association with childhood aggression (r = 0.74, p = 0.006) but no epigenome-wide significant sites were found. Top-sites (48 at a false discovery rate of 5% in the peripheral blood meta-analysis or in a combined meta-analysis of peripheral blood and cord blood) have been associated with chemical exposures, smoking, cognition, metabolic traits, and genetic variation (mQTLs). Three genes whose expression levels were associated with top-sites were previously linked to schizophrenia and general risk tolerance. At six CpGs, DNA methylation variation in blood mirrors variation in the brain. On average 44% (range = 3–82%) of the aggression–methylation association was explained by current and former smoking and BMI. These findings point at loci that are sensitive to chemical exposures with potential implications for neuronal functions. We hope these results to be a starting point for studies leading to applications as peripheral biomarkers and to reveal causal relationships with aggression and related traits.